Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.01. | Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Short Interest Update | 8 | MarketBeat | ||
09.01. | Araris Biotech kooperiert mit Chugai Pharmaceutical | 3 | punkt4.info | ||
08.01. | Chugai and Araris enter $780m ADC research collaboration | 4 | Pharmaceutical Technology | ||
17.12.24 | Warum die Chugai-Aktie am Dienstag einen Sprung machte | 6 | Investing.com Deutsch | ||
17.12.24 | Why Chugai stock jumped on Tuesday | 2 | Investing.com | ||
30.07.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 886 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen | |
CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
24.06.24 | Chugai Pharmaceutical-Aktie heute gut behauptet: Aktienwert steigt (31,305 €) | 937 | ARIVA.de | An der Börse notiert die Chugai Pharmaceutical-Aktie gegenwärtig etwas fester. Das Wertpapier notiert aktuell bei 31,31 Euro. Der Anteilsschein von Chugai Pharmaceutical verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
12.06.24 | Helsinn Healthcare S.A.: Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland | 1.062 | GlobeNewswire (Europe) | Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland
Lugano, Switzerland - June 12, 2024 - Helsinn Group ("Helsinn"), a global... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TRULIEVE CANNABIS | 3,542 | +0,68 % | Trulieve Cannabis Corp: Trulieve expands distribution of Onward beverages | ||
WEST PHARMACEUTICAL SERVICES | 200,90 | -1,57 % | West Pharmaceutical Services Aktie: Mehr als vorgesehen? | Analyse der aktuellen Börsenperformance von West Pharmaceutical Services mit strategischer Neuausrichtung nach Beendigung wichtiger Kundenpartnerschaften. Die Aktie von West Pharmaceutical Services... ► Artikel lesen | |
KALA BIO | 4,538 | -10,84 % | Oppenheimer maintains Outperform on Kala Pharmaceuticals stock | ||
SHIONOGI | 14,200 | 0,00 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
CHARLOTTES WEB | 0,088 | +6,02 % | Charlotte's Web Holdings, Inc.: Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results | 2024 Delivered Quarterly Growth and Large Scale Cost Optimization
LOUISVILLE, Colo., March 19, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's... ► Artikel lesen | |
BEXIMCO | 0,430 | -7,33 % | Dividendenbekanntmachungen (22.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASSURED GUARANTY LTD BMG0585R1060 0,31 USD 0,2959 EUR BADGER METER INC US0565251081 0,34 USD 0,3245 EUR BANK CENTRAL ASIA TBK ADR US69368G1058 0... ► Artikel lesen | |
LUYE PHARMA | 0,250 | -2,34 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH APPROVED FOR MARKETING IN JAPAN | ||
GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
PERCHERON THERAPEUTICS | 0,006 | 0,00 % | PERCHERON THERAPEUTICS LIMITED: Letter to Shareholders from the Board of Directors | ||
MIRUM PHARMACEUTICALS | 39,800 | -2,93 % | Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates | FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today provided its preliminary and unaudited estimates for full-year 2024 net product sales, year-end cash balance... ► Artikel lesen | |
AYURCANN | 0,008 | 0,00 % | Ayurcann Holdings Corp.: Ayurcann Reports Another Record Sales Growth In Q2 2025 Of $13,363,509 | Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) ("Ayurcann" or the "Company") is excited to announce record-breaking financial results for the... ► Artikel lesen | |
AVANT BRANDS | 0,700 | +1,45 % | Avant Brands Inc.: Avant Brands Reports Record Fiscal 2024 Results | Record Gross and Net Revenue: Generated $40.0 million Gross Revenue and $35.8 million Net Revenue in FY 2024.Record Export Wholesale Revenue: Generated $19.4 million in FY 2024 representing a 107% increase... ► Artikel lesen | |
EVEREST MEDICINES | 6,350 | -2,31 % | Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024 | SHANGHAI, March 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery... ► Artikel lesen | |
KALBE FARMA | 0,058 | +0,88 % | KLBF potentially distribute 45% to 55% dividend for 2024: KLBF has the potential to distribute 45% to ... | ||
KOBAYASHI PHARMACEUTICAL | 33,000 | -1,20 % | Kobayashi Pharma Promotes Toyoda to CEO |